Get the Stockscreener App
0.72
5.09%
-0.0386
Adicet Bio Inc stock is traded at $0.72, with a volume of 196.99K.
It is down -5.09% in the last 24 hours and up +2.40% over the past month.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
See More
Previous Close:
$0.7586
Open:
$0.7663
24h Volume:
196.99K
Relative Volume:
0.41
Market Cap:
$59.94M
Revenue:
$24.99M
Net Income/Loss:
$-118.64M
P/E Ratio:
-0.5496
EPS:
-1.31
Net Cash Flow:
$-100.25M
1W Performance:
-0.98%
1M Performance:
+2.40%
6M Performance:
-16.24%
1Y Performance:
-51.35%
1-Day Range:
$0.7199
$0.7672
1-Week Range:
$0.69
$0.7771
52-Week Range:
$0.4471
$1.63
Adicet Bio Inc Stock (ACET) Company Profile
Name
Adicet Bio Inc
Sector
Industry
Phone
617-482-2333
Address
131 DARTMOUTH STREET, BOSTON
Compare ACET with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACET
Adicet Bio Inc
|
0.72 | 63.16M | 24.99M | -118.64M | -100.25M | -1.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Adicet Bio Inc Stock (ACET) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-30-24 | Resumed | Guggenheim | Buy |
| Sep-11-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-27-23 | Downgrade | Guggenheim | Buy → Neutral |
| Jun-27-23 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jun-01-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-21-22 | Initiated | JP Morgan | Overweight |
| Mar-31-22 | Initiated | SMBC Nikko | Outperform |
| Mar-08-22 | Initiated | Truist | Buy |
| Mar-04-22 | Initiated | Jefferies | Buy |
| May-18-21 | Initiated | BTIG Research | Buy |
| Apr-23-21 | Initiated | H.C. Wainwright | Buy |
| Apr-14-21 | Initiated | Canaccord Genuity | Buy |
| Apr-08-21 | Initiated | Guggenheim | Buy |
| Nov-04-20 | Initiated | B. Riley Securities | Buy |
| Oct-27-20 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-20 | Initiated | Wedbush | Outperform |
View All
Adicet Bio Inc Stock (ACET) Latest News
Trend analysis for Adicet Bio Inc. this weekGap Up & Smart Allocation Stock Tips - Newser
Will Adicet Bio Inc. stock recover after recent dropForecast Cut & Consistent Profit Trading Strategies - Newser
Chart based exit strategy for Adicet Bio Inc.2025 Growth vs Value & Fast Gain Stock Trading Tips - Newser
Adicet Bio Inc. stock chart pattern explainedWeekly Trade Summary & Real-Time Buy Signal Notifications - Newser
Applying chart zones and confluence areas to Adicet Bio Inc.Share Buyback & Stock Portfolio Risk Management - Newser
Why Adicet Bio Inc. is moving todayMarket Trend Review & Advanced Swing Trade Entry Alerts - Newser
Price action breakdown for Adicet Bio Inc.2025 Earnings Impact & Free Technical Pattern Based Buy Signals - Newser
Adicet Bio (ACET) Upgraded to Buy: Here's Why - MSN
Real time breakdown of Adicet Bio Inc. stock performanceJuly 2025 Intraday Action & Accurate Trade Setup Notifications - Newser
Is Adicet Bio Inc. stock ready for a breakoutEarnings Trend Report & Stepwise Entry and Exit Trade Signals - Newser
Is now a turning point for Adicet Bio Inc.Dip Buying & Long-Term Safe Return Strategies - Newser
Bollinger Band Squeeze Points to Volatility in Adicet Bio Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Tools to assess Adicet Bio Inc.’s risk profileRate Hike & Scalable Portfolio Growth Ideas - Newser
Signal strength of Adicet Bio Inc. stock in tech scanners2025 Price Action Summary & Momentum Based Trading Ideas - Newser
Adicet Bio Grants Inducement Stock Options to New Hires Under Nasdaq Listing Rule 5635(c)(4) - AInvest
Will Adicet Bio Inc. rebound enough to break evenShort Setup & Accurate Buy Signal Alerts - Newser
Tools to monitor Adicet Bio Inc. recovery probability2025 Biggest Moves & Community Consensus Picks - Newser
What high frequency data says about Adicet Bio Inc.2025 Earnings Surprises & Stepwise Entry and Exit Trade Signals - Newser
Is Adicet Bio Inc. showing signs of accumulationTrade Entry Report & Weekly Chart Analysis and Guides - Newser
Analyzing Adicet Bio Inc. with multi timeframe chartsJuly 2025 Action & Technical Pattern Based Buy Signals - Newser
Full technical analysis of Adicet Bio Inc. stockTrade Entry Summary & Low Volatility Stock Suggestions - Newser
Can Adicet Bio Inc. Regain Momentum After Breakdown getLinesFromResByArray error: size == 0 - newsyoung.net
Strategic Talent Acquisition and Equity Incentives in Biotech: A Deep Dive into Adicet Bio’s Inducement Grants - AInvest
Adicet Bio’s Strategic Use of Inducement Grants: Balancing Talent Acquisition and Dilution Risks in a High-Stakes Biotech Landscape - AInvest
Key resistance and support levels for Adicet Bio Inc.Quarterly Performance Summary & Daily Market Momentum Tracking - Newser
Adicet Bio shares rise 2.78% after-hours after reporting inducement grants under Nasdaq Listing Rule. - AInvest
Adicet Bio reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Competitive Positioning of Adicet Bio Inc.: Is It Leading or LaggingEarnings Risk Summary & Detailed Earnings Play Alerts - Newser
Adicet Bio Inc Stock (ACET) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):